BRIEF-PDL Biopharma concludes revenue interest agreement with AxoGen Nov 14 (Reuters) - PDL BioPharma Inc (PDLI.O) :
* Announces successful conclusion of revenue interest agreement with AxoGen * Says received $30.3 million, in addition to previously received revenue interest payments
* Source text for Eikon * Further company coverage (PDLI.O)